What This Bill Does · Plain English
Summary
Plain-English summary not yet available for this bill. Check back after our next analysis run.
Action Timeline
2025-12-19
Referred to the Subcommittee on Health.
2025-08-01
Referred to the House Committee on Veterans' Affairs.
2025-08-01
Introduced in House
2025-08-01
Introduced in House
Frequently Asked Questions
Did HR.4837 pass?
HR.4837 is still alive. Current stage: COMMITTEE. Pass likelihood: pending.
Who sponsored HR.4837?
HR.4837 was sponsored by Gus M. Bilirakis (R-Florida).
Full Bill Text
119 HR 4837 IH: Written Informed Consent Act U.S. House of Representatives 2025-08-01 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. I 119th CONGRESS 1st Session H. R. 4837 IN THE HOUSE OF REPRESENTATIVES August 1, 2025 Mr. Bilirakis (for himself, Mr. Bergman , and Mr. Self ) introduced the following bill; which was referred to the Committee on Veterans' Affairs A BILL To direct the Secretary of Veterans Affairs to expand a directive of the Veterans Health Administration regarding informed consent to apply to certain types of medications. 1. Short title This Act may be cited as the Written Informed Consent Act . 2. Expansion of certain directive of the Veterans Health Administration regarding informed consent to apply to certain types of medications The Secretary of Veterans Affairs shall update VHA Directive 1005 (dated May 13, 2020, and titled Informed Consent For Long-term Opioid Therapy For Pain ) to apply to the following types of medications: (1) Antipsychotics. (2) Stimulants. (3) Antidepressants. (4) Anxiolytics. (5) Narcotics.
Loading intelligence layer…